Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease
- PMID: 11179105
- DOI: 10.1164/ajrccm.163.2.2003122
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease
Abstract
There is increasing evidence that chronic obstructive pulmonary disease (COPD) is associated with chronic inflammation in the airways and lung parenchyma; however, little is known about the inflammatory response during acute COPD exacerbation. The objectives of this study were (1) to determine if inflammatory markers associated with neutrophilic inflammation and activation increase at times of acute COPD exacerbation relative to the clinically stable state, and (2) to determine whether the presence of acute bacterial or viral infection at the time of COPD exacerbation could be correlated with increases in sputum markers of inflammation. Induced sputum was collected from patients with COPD when they were clinically stable, during the time of an acute exacerbation, and 1 mo later. Sputum was analyzed at each time point for soluble markers associated with neutrophilic inflammation; myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-8 (IL-8). Serologic assays on acute and convalescent sera were performed for respiratory viruses, and induced sputum was also subject to quantitative bacterial cultures, viral cultures, and polymerase chain reaction (PCR) for detection of respiratory viruses. Fourteen of the 50 patients enrolled in the study met predetermined criteria for an acute COPD exacerbation over the 15-mo study period. TNF-alpha and IL-8 were significantly elevated in the sputum of patients during acute COPD exacerbation compared with when they were clinically stable (p = 0.01 and p = 0.05, respectively). Concentrations of these cytokines declined significantly 1 mo after the exacerbation. Three of 14 patients (21%) had confirmed bacterial or viral respiratory tract infections. Patients with documented infection did not demonstrate greater increases in sputum levels of inflammatory cytokines during exacerbations compared with patients without demonstrable infection. We conclude that markers of airway neutrophilic inflammation increase at the time of acute COPD exacerbation and then decline 1 mo later, and that this acute inflammatory response appears to occur independently of a demonstrable viral or bacterial airway infection.
Comment in
-
Inflammatory markers in bacterial exacerbations of COPD.Am J Respir Crit Care Med. 2002 Jan 1;165(1):132. doi: 10.1164/ajrccm.165.1.145a. Am J Respir Crit Care Med. 2002. PMID: 11779743 No abstract available.
Similar articles
-
Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):947-52. doi: 10.1164/ajrccm.162.3.9908103. Am J Respir Crit Care Med. 2000. PMID: 10988111
-
[Respiratory virus infections and inflammatory cytokines in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease].Zhonghua Jie He He Hu Xi Za Zhi. 2018 Dec 12;41(12):942-948. doi: 10.3760/cma.j.issn.1001-0939.2018.12.009. Zhonghua Jie He He Hu Xi Za Zhi. 2018. PMID: 30522191 Chinese.
-
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13. Am J Respir Crit Care Med. 2008. PMID: 18079493
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
Role of viruses in exacerbations of chronic obstructive pulmonary disease.Proc Am Thorac Soc. 2004;1(2):115-20. doi: 10.1513/pats.2306030. Proc Am Thorac Soc. 2004. PMID: 16113423 Review.
Cited by
-
Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.Cell Mol Life Sci. 2013 Sep;70(17):3199-210. doi: 10.1007/s00018-013-1311-7. Epub 2013 Mar 22. Cell Mol Life Sci. 2013. PMID: 23519826 Free PMC article.
-
Chronic bronchial infection in COPD. Is there an infective phenotype?Respir Med. 2013 Jan;107(1):10-22. doi: 10.1016/j.rmed.2012.10.024. Epub 2012 Dec 4. Respir Med. 2013. PMID: 23218452 Free PMC article. Review.
-
Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.Clin Transl Med. 2015 Dec;4(1):68. doi: 10.1186/s40169-015-0068-z. Epub 2015 Jul 29. Clin Transl Med. 2015. PMID: 26220864 Free PMC article.
-
Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.J Clin Microbiol. 2012 Nov;50(11):3562-8. doi: 10.1128/JCM.00767-12. Epub 2012 Aug 22. J Clin Microbiol. 2012. PMID: 22915614 Free PMC article.
-
Th1/Th17 Cytokine Profiles are Associated with Disease Severity and Exacerbation Frequency in COPD Patients.Int J Chron Obstruct Pulmon Dis. 2020 Jun 8;15:1287-1299. doi: 10.2147/COPD.S252097. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32606639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous